Last reviewed · How we verify
NCT06947889: AID2GAIT
Biofeedback Based System to Enhance Robotic Assisted Gait Training in Children With Cerebral Palsy
trial testing RAGT in Cerebral Palsy Infantile in 11 participants. Currently enrolling.
31 March 2025
Quick facts
| Lead sponsor | G. d'Annunzio University |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 11 |
| Start date | 1 July 2024 |
| Primary completion | 31 March 2025 |
| Estimated completion | 28 February 2026 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- RAGT
Conditions studied
- Cerebral Palsy Infantile — all drugs for Cerebral Palsy Infantile →
- Robotic Assisted Gait Training — all drugs for Robotic Assisted Gait Training →
Sponsor
G. d'Annunzio University
Who can join
Adults 3 to 18, any sex, with Cerebral Palsy Infantile or Robotic Assisted Gait Training. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The AID2GAIT project aims to develop a biofeedback system with the aim of improving the outcomes of robot-assisted gait training (RAGT) in pediatric patients with cerebral palsy. The physiological signals of children during RAGT therapy sessions, acquired through non-invasive technologies, will be analyzed. These technologies specifically are: * wearable technology (smartwatch), from which the HRV (Heart Rate Variability) signal will be measured; * infrared thermography, from which the temperature in salient facial regions will be obtained; * fNIRS (functional near-infrared spectroscopy), from which information on brain activity and its changes over time will be obtained. Information on the kinematics of the exoskeleton used during RAGT will be extracted. The RAGT will be performed using the Lokomat orthosis (Hocoma), the most widely used exoskeleton in rehabilitation that facilitates a bilaterally symmetrical gait, as the individual actively tries to advance each limb during walking, combined with a patented dynamic body weight support system.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06947889
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cerebral Palsy Infantile
Currently open trials in the same condition.
- NCT07493096 — Intensive Multimodal Neurorehabilitation Targeting Neuroplasticity in Pediatric Neurodevelopmental and Chromosomal Disor · recruiting
- NCT06807203 — Motor-voice Assessment in Infants (MAMI) · recruiting
Other G. d'Annunzio University trials
Trials by the same sponsor.
- NCT07524504 — Predictive Role of the Full-mouth Plaque Score on the Outcomes of Non-surgical Periodontal Therapy. · not yet recruiting
- NCT07391202 — Crown Removal in Non-Surgical Peri-Implantitis Therapy: A Randomized Trial · NA · not yet recruiting
- NCT07048366 — Mindfulness-based Rehabilitation in a University Museum Setting to Reduce Pain and Improve Quality of Life in Women With · NA · recruiting
- NCT07013214 — Rehabilitation With Dual-task Exercises to Improve Balance in Patients With Parkinson's Disease · NA · recruiting
- NCT06923319 — Learning Curves of Different Devices for Vaginal Birth on Mannequin · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06947889 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by G. d'Annunzio University
- Last refreshed: 27 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06947889.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing